Targeting Tumor Microenvironment for Cancer Therapy, Int. J. Mol. Sci, vol.20, 2019. ,
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment, Cancer Cell, vol.21, pp.309-322, 2012. ,
Role of tumor microenvironment in tumorigenesis, J. Cancer, vol.8, pp.761-773, 2017. ,
, Front. Immunol, vol.10, 1836.
Microenvironmental regulation of metastasis, Nat. Rev. Cancer, vol.9, pp.239-252, 2009. ,
International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study, Lancet, vol.391, pp.2128-2139, 2018. ,
The Dual Role of Treg in Cancer, Scand. J. Immunol, vol.86, pp.436-443, 2017. ,
Ontogeny of Tissue-Resident Macrophages, Front. Immunol, vol.6, 2015. ,
Tissue-specific signals control reversible program of localization and functional polarization of macrophages, Cell, vol.157, pp.832-844, 2014. ,
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy, Eur. J. Cancer, vol.42, pp.717-727, 2006. ,
The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors, Nat. Immunol, vol.11, pp.373-384, 2010. ,
The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, vol.25, pp.677-686, 2004. ,
Macrophage activation and polarization: Nomenclature and experimental guidelines, Immunity, vol.41, pp.14-20, 2014. ,
Essential role of Stat6 in IL-4 signalling, Nature, vol.380, pp.627-630, 1996. ,
Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts, PLoS ONE, vol.4, p.7475, 2009. ,
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes, Cancer Immunol. Immunother, vol.68, pp.489-502, 2019. ,
The M1 and M2 paradigm of macrophage activation: Time for reassessment, vol.6, 1000. ,
Dual role of macrophage in tumor immunity, Immunotherapy, vol.10, pp.899-909, 2018. ,
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression, vol.47, 2017. ,
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, Nature, vol.475, pp.222-225, 2011. ,
CSF-1R inhibition alters macrophage polarization and blocks glioma progression, Nat. Med, vol.19, pp.1264-1272, 2013. ,
Cooperation of immune lymphoid cells with macrophages in tumour immunity, Nature, vol.228, pp.620-622, 1970. ,
Targeting macrophages: Therapeutic approaches in cancer, Nat. Rev. Drug Discov, vol.17, pp.887-904, 2018. ,
Tumor promoting role of anti-tumor macrophages in tumor microenvironment, Cell. Immunol, vol.316, pp.1-10, 2017. ,
Microenvironmental regulation of tumor progression and metastasis, Nat. Med, vol.19, pp.1423-1437, 2013. ,
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39, Nat. Neurosci, vol.22, 2019. ,
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8 + T cells through reduction of tumor-associated macrophage and activation of the interferon pathway, PLoS ONE, vol.14, 2019. ,
Iron as a Central Player and Promising Target in Cancer Progression, Int. J. Mol. Sci, vol.20, 2019. ,
Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature, PLoS ONE, vol.7, 2012. ,
Macrophages and therapeutic resistance in cancer, Cancer Cell, vol.27, pp.462-472, 2015. ,
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, Cancer Cell, vol.25, pp.846-859, 2014. ,
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling, Blood, vol.119, pp.1810-1820, 2012. ,
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas, vol.36, pp.6049-6058, 2017. ,
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer, Cancer Res, vol.75, pp.4742-4752, 2015. ,
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium phase II study, Neuro-Oncology, vol.18, pp.557-564, 2016. ,
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy, Cancer Discov, vol.1, pp.54-67, 2011. ,
Phase I Study of Emactuzumab Single Agent or in Combination with Paclitaxel in Patients with Advanced/Metastatic Solid Tumors Reveals Depletion of Immunosuppressive M2-like Macrophages, Ann. Oncol, vol.30, pp.1381-1392, 2019. ,
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase, Oncogene, vol.33, pp.3812-3819, 2014. ,
Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer, Immunobiology, vol.224, pp.355-361, 2019. ,
Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization, Neuro-Oncology, vol.18, pp.797-806, 2016. ,
Bisphosphonates for treatment and prevention of bone metastases, J. Clin. Oncol, vol.23, pp.8219-8224, 2005. ,
Clodronate-liposome-mediated depletion of tumour-associated macrophages: A new and highly effective antiangiogenic therapy approach, Br. J. Cancer, vol.95, pp.272-281, 2006. ,
Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo, J. Invest. Dermatol, vol.134, pp.2814-2822, 2014. ,
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages, Cancer Sci, vol.99, pp.1595-1602, 2008. ,
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth, PLoS ONE, vol.4, 2009. ,
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft, J. Invest. Dermatol, vol.127, pp.2031-2041, 2007. ,
Reduction in new metastases in breast cancer with adjuvant clodronate treatment, N. Engl. J. Med, vol.339, pp.357-363, 1998. ,
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials, Pharmacol. Ther, vol.158, pp.24-40, 2016. ,
Role of macrophage targeting in the antitumor activity of trabectedin, Cancer Cell, vol.23, pp.249-262, 2013. ,
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment, Oncotarget, vol.7, pp.41662-41676, 2016. ,
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis, Cell Rep, vol.15, 2000. ,
Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages, Cell. Immunol, vol.313, pp.52-58, 2017. ,
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients, Cancer Cell, vol.29, pp.587-601, 2016. ,
IFN? and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma, Cancer Discov, vol.6, pp.400-413, 2016. ,
Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor-conditioned macrophages, Eur. J. Immunol, vol.49, pp.801-811, 2019. ,
Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model, Mol. Med. Rep, vol.12, pp.3515-3520, 2015. ,
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours, Eur. J. Cancer, vol.51, pp.146-156, 2015. ,
Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis ,
Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody, J. Immunol, vol.168, pp.2720-2728, 2002. ,
Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors, Cancer Biol. Ther, vol.10, pp.983-993, 2010. ,
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies, Mol. Ther, vol.25, pp.523-533, 2017. ,
Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide, J. Immunol, vol.162, pp.6811-6818, 1999. ,
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses, Nat. Biotechnol, vol.27, pp.925-932, 2009. ,
Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer, FASEB J, vol.32, pp.969-978, 2018. ,
MicroRNA-mediated control of macrophages and its implications for cancer, Trends Immunol, vol.34, pp.350-359, 2013. ,
miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis, Immunity, vol.38, pp.1236-1249, 2013. ,
Suppression of microRNA activity amplifies IFN-?-induced macrophage activation and promotes anti-tumour immunity, Nat. Cell Biol, vol.18, pp.790-802, 2016. ,
Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway, Cancer Res, vol.72, pp.1363-1372, 2012. ,
PI3K? is a molecular switch that controls immune suppression, Nature, vol.539, pp.437-442, 2016. ,
Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate, J. Leukoc. Biol, vol.91, pp.609-619, 2012. ,
CYP4 × 1 Inhibition by Flavonoid CH625 Normalizes Glioma Vasculature through Reprogramming TAMs via CB2 and EGFR-STAT3 Axis, J. Pharmacol. Exp. Ther, vol.365, pp.72-83, 2018. ,
Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin, Cell Death Dis, vol.6, 1942. ,
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages, Nature, vol.543, pp.428-432, 2017. ,
Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner, Cancer Res, vol.78, pp.5891-5900, 2018. ,
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity, J. Exp. Med, vol.215, pp.877-893, 2018. ,
Macrophages and CD8 + T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors, Cancer Immunol. Res, vol.6, pp.434-447, 2018. ,
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy, Cancer Immunol. Immunother, vol.63, pp.787-796, 2014. ,
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis, Cell. Mol. Immunol, 2018. ,
The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression, Nat. Commun, vol.10, 1034. ,
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, vol.513, pp.559-563, 2014. ,
Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis, Proc. Natl. Acad. Sci, vol.114, pp.580-585, 2017. ,
GADD45? Loss Ablates Innate Immunosuppression in Cancer, Cancer Res, vol.78, pp.1275-1292, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02118047
Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages, Am. J. Cancer Res, vol.7, pp.2220-2233, 2017. ,
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer, Nat. Commun, vol.10, 2019. ,
Fatty acid oxidation contributes to IL-1? secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration, Mol. Immunol, vol.94, pp.27-35, 2018. ,
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression, Cell Metab, vol.29, pp.1376-1389, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02359441
The CCR2 + Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers, Cell. Mol. Gastroenterol. Hepatol, vol.7, pp.371-390, 2019. ,
The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy, Cancer Immunol. Res, vol.6, pp.1337-1351, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02356000
Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion, Cancer Res, vol.79, pp.3903-3915, 2019. ,
Targeting both tumour-associated CXCR2 + neutrophils and CCR2 + macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma, Gut, vol.67, pp.1112-1123, 2018. ,
CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages, Front. Oncol, vol.9, p.231, 2019. ,
Bentires-Alj, M. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis, Nature, vol.515, pp.130-133, 2014. ,
Chemokine receptor-specific antibodies in cancer immunotherapy: Achievements and challenges, Front. Immunol, vol.6, 2015. ,
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors, Cancer Chemother. Pharmacol, vol.71, pp.1041-1050, 2013. ,
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer, Invest. New Drugs, vol.31, pp.760-768, 2013. ,
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial, Lancet Oncol, vol.17, pp.651-662, 2016. ,
Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy, Sci. Rep, vol.9, 2019. ,
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors, Clin. Cancer Res, vol.23, pp.5703-5710, 2017. ,
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: A dose-escalation and dose-expansion phase 1 study, Lancet Oncol, vol.16, pp.949-956, 2015. ,
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors, J. Hematol. Oncol, vol.12, issue.9, 2019. ,
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor, Oncologist, vol.24, pp.1-8, 2019. ,
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts, J. Pathol, 2019. ,
Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages, Brain Behav. Immun, vol.81, pp.111-121, 2019. ,
Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer, Exp. Cell Res, vol.366, pp.127-138, 2018. ,
Control of regulatory T cell development by the transcription factor Foxp3, Science, vol.299, pp.1057-1061, 2003. ,
Anti-CCR4 mAb selectively depletes effector-type FoxP3 + CD4 + regulatory T cells, evoking antitumor immune responses in humans, Proc. Natl. Acad. Sci, vol.110, pp.17945-17950, 2013. ,
Cutting edge: CD28 controls peripheral homeostasis of CD4 + CD25 + regulatory T cells, J. Immunol, vol.171, pp.3348-3352, 2003. ,
Stimulation of CD25 + CD4 + regulatory T cells through GITR breaks immunological self-tolerance, Nat. Immunol, vol.3, pp.135-142, 2002. ,
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 + CD4 + regulatory cells that control intestinal inflammation, J. Exp. Med, vol.192, pp.295-302, 2000. ,
Role of LAG-3 in regulatory T cells, Immunity, vol.21, pp.503-513, 2004. ,
Interferon-? Drives Treg Fragility to Promote Anti-tumor Immunity, vol.169, pp.1130-1141, 2017. ,
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy, vol.129, pp.2186-2197, 2017. ,
Novel Effector Phenotype of Tim-3 + Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients, Clin. Cancer Res, vol.24, pp.4529-4538, 2018. ,
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses, Immunity, vol.40, pp.569-581, 2014. ,
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses, J. Exp. Med, vol.208, pp.577-592, 2011. ,
How regulatory T cells work, Nat. Rev. Immunol, vol.8, pp.523-532, 2008. ,
Naturally arising CD4 + regulatory t cells for immunologic self-tolerance and negative control of immune responses, Annu. Rev. Immunol, vol.22, pp.531-562, 2004. ,
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance, Immunity, vol.27, pp.635-646, 2007. ,
CD4 + CD25 + Foxp3 + regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4 + T cells, Nat. Immunol, vol.8, pp.1353-1362, 2007. ,
Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers, Nat. Med, vol.22, pp.679-684, 2016. ,
Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells, J. Immunol, vol.173, pp.1444-1453, 2004. ,
Intratumoral CD4 + CD25 + regulatory T-cell-mediated suppression of infiltrating CD4 + T cells in B-cell non-Hodgkin lymphoma, Blood, vol.107, pp.3639-3646, 2006. ,
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J. Immunol, vol.169, pp.2756-2761, 2002. ,
Regulatory CD4 + CD25 + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, Cancer Res, vol.61, pp.4766-4772, 2001. ,
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation, Am. J. Transplant, vol.8, pp.2086-2096, 2008. ,
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients, Sci. Transl. Med ,
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer, J. Clin. Invest, vol.127, pp.801-813, 2017. ,
Phase Ia Study of FoxP3 + CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients, Clin. Cancer Res, vol.21, pp.4327-4336, 2015. ,
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes, J. Exp. Med, vol.216, pp.1170-1181, 2019. ,
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects, Front. Immunol, vol.9, 2018. ,
Rational design of anti-GITR-based combination immunotherapy, Nat. Med, vol.25, pp.759-766, 2019. ,
Agonism Enhances Cellular Metabolism to Support CD8 + T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model, Cancer Immunol. Res, vol.6, pp.1199-1211, 2018. ,
Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin, J. Immunol, pp.3647-3661, 0200. ,
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing, vol.169, pp.1342-1356, 2017. ,
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma, J. Exp. Med, vol.210, pp.1695-1710, 2013. ,
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations, Sci. Transl. Med, 2016. ,
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer, Proc. Natl. Acad. Sci, vol.116, pp.9999-10008, 2019. ,
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent, vol.355, pp.1423-1427, 2017. ,
LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo, Activation Gene, vol.3, 2014. ,
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action, Int. J. Mol. Sci, vol.18, p.645, 2017. ,
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226, J. Immunol, vol.195, pp.145-155, 2015. ,
VISTA Regulates the Development of Protective Antitumor Immunity, Cancer Res, vol.74, pp.1933-1944, 2014. ,
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma, Oral Oncol, vol.57, pp.54-60, 2016. ,
DAB(389)IL-2 (denileukin diftitox, ONTAK): A new fusion protein technology, Clin Lymphoma, vol.1, pp.27-31, 2000. ,
Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma, Proc. Natl. Acad. Sci, vol.116, pp.3100-3105, 2019. ,
Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment, Onco Targets Ther, vol.9, pp.243-253, 2016. ,
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma, Onco Targets Ther, vol.10, pp.503-514, 2017. ,
Improved Anti-Treg Vaccination Targeting Foxp3 Efficiently Decreases Regulatory T Cells in Mice, J. Immunother, vol.39, pp.269-275, 2016. ,
Prophylactic DNA vaccine targeting Foxp3 + regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model, Cancer Immunol. Immunother, vol.67, pp.367-379, 2018. ,
CD4 + CD25 + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, Eur. J. Immunol, vol.34, pp.336-344, 2004. ,
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome, Cancer Immunol. Immunother, vol.61, pp.353-362, 2012. ,
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer, Clin. Cancer Res, vol.23, pp.6771-6780, 2017. ,
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: A current perspective, Cancer Res, vol.72, pp.3439-3444, 2012. ,
T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development, Immunity, vol.37, pp.785-799, 2012. ,
Inactivation of PI(3)K p110? breaks regulatory T-cell-mediated immune tolerance to cancer, Nature, vol.510, pp.407-411, 2014. ,
Differential PI3K? Signaling in CD4 + T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy, Cancer Res, vol.77, pp.1892-1904, 2017. ,
TGF-beta: A master of all T cell trades, Cell, vol.134, pp.392-404, 2008. ,
,
, Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance, vol.21, pp.1853-1869, 2017.
Adaptive plasticity of IL-10 + and IL-35 + Treg cells cooperatively promotes tumor T cell exhaustion, Nat. Immunol, vol.20, pp.724-735, 2019. ,
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors, vol.46, pp.577-586, 2017. ,
Multilineage potential of adult human mesenchymal stem cells, Science, vol.284, pp.143-147, 1999. ,
Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies, Stem Cells Int, vol.6854080, 2019. ,
Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation, Stem Cells, vol.35, pp.1603-1613, 2017. ,
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells, Cytotherapy, vol.18, pp.160-171, 2016. ,
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma, J. Exp. Med, vol.203, pp.1235-1247, 2006. ,
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling, Cancer Lett, vol.269, pp.67-77, 2008. ,
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages, Cancer Lett, vol.326, pp.59-68, 2012. ,
Concise review: Growth differentiation factor 15 in pathology: A clinical role?, Stem Cells Transl. Med, vol.2, pp.946-952, 2013. ,
Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth, Oncogene, vol.38, pp.1576-1584, 2019. ,
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression, J. Clin. Invest, vol.123, pp.1542-1555, 2013. ,
Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo, Cancer Lett, vol.315, pp.28-37, 2012. ,
Interactions between mesenchymal stem cells and the immune system, Cell. Mol. Life Sci, vol.74, pp.2345-2360, 2017. ,
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation, Cell Death Dis, 2013. ,
Role of MSCs in antitumor drug resistance, Mesenchymal Stromal Cells as Tumor Stromal Modulators ,
, , pp.295-333, 2016.
Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours, PLoS ONE, vol.3, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02472253
Cancer associated fibroblasts'-more than meets the eye, Trends Mol. Med, vol.19, pp.447-453, 2013. ,
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.449, pp.557-563, 2007. ,
Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D, Exp. Cell Res, vol.383, 2019. ,
, Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth. Cell Rep, vol.18, pp.1215-1228, 2017.
, Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B. Sci. Rep, vol.9, 2019.
Leptin receptor antagonism of iNKT cell function: A novel strategy to combat multiple myeloma, vol.31, pp.2678-2685, 2017. ,
Activation and Differentiation of Mesenchymal Stem Cells, Methods Mol. Biol, vol.1554, pp.201-209, 2017. ,
CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer, Mol. Cancer, vol.17, pp.47-51, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01716892
Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors, J. Mol. Cell Biol, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02390801
DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death, Sci. Rep, vol.8, p.17862, 2018. ,
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia-results of a phase I dose-escalation study, Clin. Lymphoma Myeloma Leuk, vol.15, pp.443-449, 2015. ,
Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC), Cell Commun. Signal, vol.16, issue.2, 2018. ,
Eph/Ephrin-mediated stimulation of human bone marrow mesenchymal stromal cells correlates with changes in cell adherence and increased cell death, Stem Cell Res. Ther, vol.9, p.172, 2018. ,
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism, Oncotarget, vol.10, pp.3435-3450, 2019. ,
Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents, J. Natl. Cancer Inst, vol.96, pp.1593-1603, 2004. ,
Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma, Cancer Res, vol.79, pp.4503-4514, 2019. ,
Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy, Mol. Cancer, vol.17, 2018. ,
Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci, Mol. Cancer, vol.17, 2018. ,
Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration, Mol. Cell. Biochem, vol.458, pp.11-26, 2019. ,
Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells, Cancers ,
A stromal address code defined by fibroblasts, Trends Immunol, vol.26, pp.150-156, 2005. ,
Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: An important autocrine/paracrine factor in tumor progression, Cancer Sci, vol.97, pp.1061-1069, 2006. ,
Anatomic demarcation by positional variation in fibroblast gene expression programs, PLoS Genet, 2006. ,
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs, Cell, vol.129, pp.1311-1323, 2007. ,
The extracellular matrix at a glance, J. Cell Sci, vol.123, pp.4195-4200, 2010. ,
Fibroblasts as architects of cancer pathogenesis, Biochim. Biophys. Acta, vol.1832, pp.1070-1078, 2013. ,
Wound healing and the role of fibroblasts, J. Wound Care, vol.22, pp.407-408, 2013. ,
Host responses in tissue repair and fibrosis, Annu. Rev. Pathol, vol.8, pp.241-276, 2013. ,
Methylation determines fibroblast activation and fibrogenesis in the kidney, Nat. Med, vol.16, pp.544-550, 2010. ,
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation, Nat. Cell Biol, vol.17, pp.1193-1204, 2015. ,
LIF mediates proinvasive activation of stromal fibroblasts in cancer, Cell Rep, vol.7, pp.1664-1678, 2014. ,
A peek into cancer-associated fibroblasts: Origins, functions and translational impact, Dis. Model Mech, vol.11, 2018. ,
Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer, J. Exp. Med, vol.215, pp.3075-3093, 2018. ,
Pancreatic cancer associated fibroblasts display normal allelotypes, Cancer Biol. Ther, vol.7, pp.882-888, 2008. ,
Toward a genetics of cancer resistance, Proc. Natl. Acad. Sci, vol.106, pp.859-863, 2009. ,
Biology of pancreatic stellate cells-more than just pancreatic cancer, vol.469, pp.1039-1050, 2017. ,
Fibroblast heterogeneity: Implications for human disease, J. Clin. Invest, vol.128, pp.26-35, 2018. ,
, Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. Cancer Cell, vol.33, pp.463-479, 2018.
Inter-and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma, J. Pathol, vol.248, pp.51-65, 2019. ,
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer, Nat. Med, vol.15, pp.68-74, 2009. ,
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer, J. Exp. Med, vol.214, pp.579-596, 2017. ,
A FATal Combination: Fibroblast-Derived Lipids and Cancer-Derived Autotaxin Promote Pancreatic Cancer Growth, Cancer Discov, vol.9, pp.578-580, 2019. ,
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing, Nat. Commun, vol.9, p.5150, 2018. ,
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts, Cancer Discov, vol.9, pp.1102-1123, 2019. ,
Identification of fibroblast heterogeneity in the tumor microenvironment, Cancer Biol. Ther, vol.5, pp.1640-1646, 2006. ,
The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, vol.16, pp.582-598, 2016. ,
Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac, FASEB J, vol.18, pp.1016-1018, 2004. ,
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, vol.121, pp.335-348, 2005. ,
Barshack, I. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors, Biochem. Biophys. Res. Commun, vol.437, pp.397-402, 2013. ,
TGF-beta in CAF-mediated tumor growth and metastasis, Semin. Cancer Biol, vol.25, pp.15-22, 2014. ,
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma, J. Pathol, vol.235, pp.466-477, 2015. ,
Chung, I. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway, Am. J. Cancer Res, vol.6, pp.200-213, 2016. ,
Carcinoma-associated fibroblasts: Orchestrating the composition of malignancy, Genes Dev, vol.30, pp.1002-1019, 2016. ,
Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance, EMBO Mol. Med, vol.7, pp.735-753, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02421448
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts, Oncotarget, vol.7, pp.41584-41598, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02421440
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression, Cancer Discov, vol.9, pp.617-627, 2019. ,
Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth, Cell Metab, vol.24, pp.685-700, 2016. ,
Remodelling the extracellular matrix in development and disease, Nat. Rev. Mol. Cell Biol, vol.15, pp.786-801, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01952416
Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease, Trends Cell Biol, vol.26, pp.486-497, 2016. ,
A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion, Nat. Cell Biol, vol.19, pp.224-237, 2017. ,
Exosome-Mediated Metastasis: Communication from a Distance, Dev. Cell, vol.49, pp.347-360, 2019. ,
Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer, PLoS Med, vol.12, 2015. ,
Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/beta-catenin pathway, Cancer Res, vol.72, pp.4652-4661, 2012. ,
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis, Cell, vol.123, pp.1001-1011, 2005. ,
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer, J. Clin. Oncol, vol.33, pp.4284-4292, 2015. ,
Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma, JCI Insight, vol.2, p.92232, 2017. ,
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival, Cancer Cell, vol.25, pp.719-734, 2014. ,
Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: Activation of the thymidine phosphorylase as active principle? Onkologie, vol.26, pp.161-164, 2003. ,
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer, Cancer Biol. Ther, vol.6, pp.1691-1699, 2007. ,
CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness, Cell, vol.172, pp.841-856, 2018. ,
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors, Ann. Oncol, vol.25, pp.1416-1421, 2014. ,
Recent advances in the discovery of small molecule c-Met Kinase inhibitors, Eur. J. Med. Chem, vol.143, pp.1103-1138, 2018. ,
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy, Cell, vol.159, pp.80-93, 2014. ,
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer, Cancer Lett, vol.420, pp.247-258, 2018. ,
Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug, J. Natl. Cancer Inst, vol.104, pp.1320-1334, 2012. ,
Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides, Biomaterials, vol.34, pp.4137-4149, 2013. ,
Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells, Biomaterials, vol.54, pp.148-157, 2015. ,
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-? signaling, Nat. Immunol, vol.18, pp.995-1003, 2017. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI